Countdown to 2030: eliminating hepatitis B disease, China

Hepatitis B virus (HBV) infection is a major public health problem worldwide.China has the world's largest burden of HBV infection and will be a major contributor towards the global elimination of hepatitis B disease by 2030.The country has made good progress in reducing incidence of HBV infection in the past three decades.The achievements are mainly due to high vaccination coverages among children and high coverage of timely birth-dose vaccine for prevention of mother-to-child transmission of HBV (both > 95%).However, China still faces challenges in achieving its target of 65% reduction in mortality from hepatitis B by 2030.Based on targets of the World Health Organization's Global health sector strategy on viral hepatitis 2016-2021, we highlight further priorities for action towards HBV elimination in China.To achieve the impact target of reduced mortality we suggest that the service coverage targets of diagnosis and treatment should be prioritized.First, improvements are needed in the diagnostic and treatment abilities of medical institutions and health workers.Second, the government needs to reduce the financial burden of health care on patients.Third, better coordination is needed across existing national programmes and resources to establish an integrated prevention and control system that covers prevention, screening, diagnosis and treatment of HBV infection across the life cycle.In this way, progress can be made towards achieving the target of eliminating hepatitis B in China by 2030.